Event Details

This document is page 76 of a Cowen Collaborative Insights report dated February 25, 2019. It details regulatory challenges and updates regarding CBD and hemp products, specifically focusing on FDA regulations and state-level legislation in California (Assembly Bill 2914). The document bears a 'HOUSE_OVERSIGHT' footer, suggesting it was part of a document production for a congressional investigation, though the content itself is strictly related to cannabis industry regulation and contains no direct mention of Jeffrey Epstein or his associates.